U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/< Back ToThe Science/Complement and Inflammation Research
  Complement and Inflammation Research
    The Laboratory for Complement and Inflammation Research, led by Dr. Claudia Kemper, aims to understand the unexpected roles of complement proteins in the regulation of key basic processes of the cell in health and disease.
    On This Page
    
          Claudia Kemper
  Claudia Kemper, Ph.D.
          Senior Investigator
          Email
      Meet the Team
            Contact us
  Senior Investigator Research Interests
            
  Research Interests
              Our laboratory aims at understanding the unexpected roles of intracellularly active complement in the regulation of key basic processes of the cell in health and disease.Complement is generally well appreciated as a serum-effective system and critical arm of innate immunity required for the detection and removal of invading pathogens. Work from Dr. Kemper's lab, however, has highlighted an equally profound impact of complement on adaptive immunity through direct regulation of CD4+ T cells: signals mediated by T cell-expressed anaphylatoxin receptor C3aR and the complement regulator CD46 (which binds the complement activation fragment C3b) are critical checkpoints in human T cell lineage commitment and control initiation and resolution of inflammatory Th1 responses. Further, they have discovered that activation of the key complement components C3 and C5 is not confined to the extracellular space but occurs intracellulary (the ‘Complosome’) and that intracellular C3 and C5 activation fundamentally dictates the magnitude of Th1-mediated inflammation, the production of granzyme B and IFN-g by cytotoxic CD8+ T cells and the secretion of highly proinflammatory IL-1b by monocytes and macrophages. Consequently, perturbations in complosome activity in immune cells contributes majorly to a range of human disease states, including recurrent infections, autoimmunity (arthritis, SLE, CAPS, and scleroderma), chronic organ rejection, cancer, and cardiovascular disease.Likely the most exciting recent development in their work is the observation that intracellular C3 and C5 are unexpected critical orchestrators of basic cellular processes, including the control of cell metabolism (induction of nutrient flux, glycolysis and oxidative phosphorylation), mitochondrial activity (directionality of the electron transport chain (ETC), impact on TCA cycle and ROS production) and gene transcription. Thus, CIRS has created a novel research area and propose that understanding the unexpected functions of the complosome will deliver critical new knowledge about cell biology in health and disease.The central goal of Dr. Kemper's research programme is therefore to define the functional roles and regulative mechanisms of intracellular/autocrine complement and assess their biological relevance with an eye on delivering druggable targets in these pathways to therapeutically intervene in diseases (recently, the lab has broadened its interest heavily towards the role of the complosome in meningeal immunity and neurodegenerative disorders (such as MS)). To achieve this overarching goal, Dr. Kemper's lab are currently focusing on three key questions:What is the composition of the Complosome in different cells?What are the functions of the Complosome?How is the Complosome regulated?They utilize immune/tissue cells from healthy donors, from patients with complement deficiencies, from patients with immune cell-driven infectious, autoimmune disease or cancer and from patients with deviations in novel ‘complosome’-regulated pathways for gene and scRNA arrays, epigenetic landscape evaluation, and (spatial) proteomic and metabolomic assessments. This unbiased approach driven by human genetics and robust experimental in vitro systems will be combined with appropriate small animal (mouse) in vivo models to define biological significance of proteins/pathways discovered and to develop preclinical animal models for future pharmacological targeting. To achieve the latter, the Kemper lab is collaborating via a CRADA with Apellis Pharmaceuticals, Inc.
  Featured Publications
                Intracellular complement activations sustains T cell homeostasis and mediates effector function.
            Authors:Liszewski, MK, Kolev, M, Le Friec, G, Leung, M, Bertram, PG, Fara, A, Subias, M, Pickering, MP, Drouet, C, Meri, S, Arstilla, TP, Pekkarinen, Ma, M, Cope, A, Reinheckel, T, Rodriguez de Cordoba, S, Afzali, B, Atkinson, JP, and Kemper, C.
                                                                                                                        
            Immunity
      
                2013 Jan 01;39(6):1143-1157
        Read Publication
                      Complement mediates nutrient influx and metabolic reprogramming in Th1 responses.
            Authors:Kolev, M, Dimeloe, S, Le Friec, G, Arbore, G, Povoleri, GA, Fischer, M, Razik, L, Watson, J, Couzi, L, Afzali, B, Lavender, P, Hess, C, and Kemper, C.
                                                                                                                        
            Immunity
      
                2015 Jan 01;42(6):1033-1047
        Read Publication
                      CD4+ T cell-intrinsic complement-NLRP3 inflammasome activity regulates IFN-g production
            Authors:Arbore, G, West EE, Spolski, R, Robertson, AB, Klos, A, Rheinheimer, C, Dutow, P, Woodruff, TM, O'Neill, LA, Coll, RC, Sher, A, Leonard, WJ, Monk, P, Cooper, MA, Arno, M, Afzali, B, Lachmann, HJ, Cope, AP, Mayer-Barber, K, and Kemper, C.
                                                                                                                        
            Science
      
                2016 Jan 01;17(352):6292
        Read Publication
                      Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation.
            Authors:Niyonzima, N, Rahman, J, Kunz, N, ... Espevik, T, and Kemper, C.
                                                                                                                        
            Sci Immunol
      
                2021 Jan 01;6(66):
        Read Publication
  Meet the Team

    Claudia Kemper

            Claudia Kemper, Ph.D.
                Senior Investigator
                Dr. Kemper is a Senior Investigator and Section Chief at the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, Maryland.Dr. Kemper received her Ph.D. in 1998 from the Bernhard-Nocht-Institute for Tropical Medicine, in Germany, and joined John Atkinson’s laboratory as a postdoctoral fellow at Washington University (Saint Louis) in 1999. Here, she discovered that the complement regulator CD46 is a key checkpoint in human Th1 induction. Dr. Kemper moved to King’s College London in 2008, where her group discovered the intracellularly active complement (the complosome) which serves non-canonical roles in cell biology, including the regulation of key metabolic pathways, mitochondrial dynamics, and gene transcription. Her group further showed that complosome perturbations are associated with a range of human diseases, including primary immune deficiency, and arthritic and cardiovascular disease.Dr. Kemper is the recipient of a Wellcome Trust Investigator Award, the Merit Award for Excellence in Science from the International Complement Society, two Orloff Awards in Science from the NHLBI/NIH. She is an elected member of the Henry Kunkel Society, serves on the Scientific Board of Apellis, Inc., is the current NHLBI representative of the Women Scientists Advisors (WSA), a current member of the American Association of Immunologists (AA) Committee on the Status of Women, the Head of Admission of the NIH-OXCAM Scholars Program, and the sitting President of the International Complement Society.
    
          Contact the lab
    10 Center DrBethesda, MD 20814United States
        Phone:
                    301-451-2872
                Fax:
  Rahman
    
            Muhammad Jubayer Rahman, Ph.D.
        

    Staff Scientist

        jubayer.rahman@nih.gov
            Erin West
    
            Erin West, Ph.D.
        

    Staff Scientist

        westee2@mail.nih.gov
            Dr. Parul Singh
    
            Parul Singh, Ph.D.
        

    Postdoctoral Fellow

        parul.singh@nih.gov
            Natalia Kunz
    
            Natalia Kunz, Ph.D.
        

    Postdoctoral Fellow

        natalia.kunz@nih.gov
            Nicolas Merles
    
            Nicolas Merles, Ph.D.
        

    Postdoctoral Fellow
            Jack Bibby
    
            Jack Bibby, Ph.D.
        

    Postdoctoral Fellow

        jack.bibby@nih.gov
            Beltran
    
            Emily Beltran
        

    Ph.D. Student, NIH-OXCAM Program

        emily.beltran@nih.gov
            Adam F. Maleki, M.Sc., Ph.D.
    
            Adam F. Maleki, M.Sc., Ph.D.
        

    Visiting Fellow

        adam.fanimaleki@nih.gov
            Ayden Case
        

    Ph.D. Student, NIH-OXACM Scholars Program and Gates Cambridge

        ayden.case@nih.gov
                    Load more members
  
  Alumni
        

Martin Kolev, Ph.D.
        

    Visiting Scientist
                                        2017

      -
            2018
        Martin Kolev, Ph.D. is currently a Associate Director at Apellis Pharmaceuticals, Inc. Boston, MS, USA.
      Leo Placais
        

    Clinical MSc Student
                                        2018

      -
            2019
        Leo Placais  is currently a Clinical Student at Faculté de médecine Pierre et Marie Curie, Université Paris VI in Paris, France.
      Nathalie Niyonzima
        

    Research Fellow
                                        2017

      -
            2019
        Nathalie Niyonzima  is currently a Research Fellow at NTNU in Trondheim, Norway.
      Tilo Freiwald, M.D., Ph.D.
        

    Visiting Fellow
                                        2018

      -
            2022
        Tilo Freiwald, M.D., Ph.D. is currently a Junior Clinical Group Leader at HCKH (Hamburg Center for Kidney Health, of the University Hospital Eppendorf in Hamburg, Germany).
      Luciana Negro Demontel, Ph.D.
        

    Postdoctoral Fellow
                                        2021

      -
            2023
        Luciana Negro Demontel, Ph.D. is currently a Senior Research Scientist at Drexel University School of Biomedical Engineering.
      Daniel Seiler, Ph.D.
        

    Ph.D. Student
        Daniel Seiler, Ph.D. is currently a Postdoctoral Fellow  at University of Lubeck, ISEF (Institute for systemic inflammatory research), Lubeck, Germany.
      Stanley Odidika, Ph.D.
        

    Ph.D. Student
        Stanley Odidika, Ph.D. is currently a Postdoctoral Fellow at University of Cologne, Cologne, Germany.

          Load more alumni Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs